Bicara Therapeutics (BCAX) Q1 2024 Earnings
BCAX·Reported September 13, 2024
Diluted EPS came in at $-0.27.
Diluted EPS
$-0.27
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about Bicara Therapeutics's Q1 2024 earnings report.
Bicara Therapeutics (BCAX) reported Q1 2024 earnings on September 13, 2024.
Bicara Therapeutics reported diluted EPS of $-0.27 for Q1 2024.